Tennessee – Tennessee Attorney General Jonathan Skrmetti announced Monday the official launch of a restitution claims process for former patients of HRC Medical Centers, following years of litigation over the company’s deceptive advertising of hormone therapy treatments.
The announcement marks a key development in a case dating back to 2012, when the Attorney General’s Office filed suit against HRC, accusing the company of misleading consumers about the safety and effectiveness of its bioidentical hormone replacement therapy treatments. The lawsuit resulted in an $18 million judgment against HRC in 2017.
After prolonged efforts to collect on that judgment, Skrmetti’s office has recovered approximately $1.5 million in available assets. These funds will now be distributed to eligible consumers harmed by the company’s practices.
“For more than a decade, our office has worked hard to protect consumers and secure restitution from HRC Medical Centers for misleading Tennesseans about the safety and efficacy of life-altering treatments,” Skrmetti said. “While we are disappointed we could not recover more, we’ve known for a long time that funds would be limited and we fought to obtain every possible dollar for consumers.”
Former HRC customers who received treatments at the company’s Tennessee clinics — located in Nashville, Knoxville, and Memphis — may qualify for restitution. Each claimant could receive up to $2,250, depending on the number of valid claims submitted. The payments are strictly for deceptive marketing damages and do not cover medical malpractice or physical injury claims, which were not part of the lawsuit.
To be eligible, consumers must complete and submit a claim form by August 30, 2025.
The Attorney General’s Office encourages those who believe they qualify to act promptly. Additional information, including how to submit a claim, can be found through the official website or by contacting the Office directly.
The restitution process comes as a resolution for many Tennesseans who say they were misled into pursuing hormone treatments that failed to live up to their advertised promises. The Office emphasized that while full restitution was not financially possible, every available dollar recovered has been dedicated to compensating affected consumers.